SG73627A1 - Production method of isoxazolidnedione compound - Google Patents

Production method of isoxazolidnedione compound

Info

Publication number
SG73627A1
SG73627A1 SG1999001563A SG1999001563A SG73627A1 SG 73627 A1 SG73627 A1 SG 73627A1 SG 1999001563 A SG1999001563 A SG 1999001563A SG 1999001563 A SG1999001563 A SG 1999001563A SG 73627 A1 SG73627 A1 SG 73627A1
Authority
SG
Singapore
Prior art keywords
isoxazolidnedione
compound
production method
production
isoxazolidnedione compound
Prior art date
Application number
SG1999001563A
Other languages
English (en)
Inventor
Ando Koji
Suzuki Masanobu
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of SG73627A1 publication Critical patent/SG73627A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1999001563A 1998-03-30 1999-03-30 Production method of isoxazolidnedione compound SG73627A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10409898 1998-03-30

Publications (1)

Publication Number Publication Date
SG73627A1 true SG73627A1 (en) 2000-06-20

Family

ID=14371652

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1999001563A SG73627A1 (en) 1998-03-30 1999-03-30 Production method of isoxazolidnedione compound

Country Status (25)

Country Link
US (4) US6248897B1 (de)
EP (3) EP1384722A1 (de)
JP (1) JP2000143596A (de)
KR (1) KR100321608B1 (de)
CN (4) CN1235887C (de)
AR (1) AR015745A1 (de)
AT (1) ATE258931T1 (de)
AU (1) AU738200B2 (de)
BR (1) BR9906312A (de)
CA (1) CA2291620C (de)
CO (1) CO5080736A1 (de)
CZ (1) CZ296507B6 (de)
DE (1) DE69914557T2 (de)
ES (1) ES2211053T3 (de)
HU (1) HUP0003273A3 (de)
IL (1) IL133146A (de)
NO (4) NO314403B1 (de)
NZ (1) NZ501896A (de)
PE (1) PE20000359A1 (de)
RU (1) RU2180663C2 (de)
SG (1) SG73627A1 (de)
SK (1) SK161499A3 (de)
TW (1) TWI224594B (de)
WO (1) WO1999050267A1 (de)
ZA (1) ZA997705B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1235887C (zh) * 1998-03-30 2006-01-11 日本烟草产业株式会社 噁唑基乙醇衍生物的制备方法
US6958355B2 (en) 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
AU2001294673A1 (en) * 2000-09-21 2002-04-02 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
BR0208956A (pt) * 2001-04-16 2004-07-13 Tanabe Seiyaku Co Abridor de canais de k ativados por cálcio de grande condutância
US6696474B2 (en) * 2002-04-03 2004-02-24 Warner Lambert Co. Llc. Antidiabetic agents
US6716842B2 (en) * 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
AR041481A1 (es) * 2002-10-07 2005-05-18 Hoffmann La Roche Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar
DE10328174A1 (de) * 2003-06-24 2005-01-13 Bayer Healthcare Ag Verfahren zur Herstellung von Aryloxazolylethylalkohol
MX2007011546A (es) * 2005-03-22 2007-10-19 Hoffmann La Roche Nueva sal y polimorfos del inhibidor de dipeptidil-peptidasa iv.
EP1892231A1 (de) * 2006-08-21 2008-02-27 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Deoxofluorenierung von Ketonen im grosstechnischen Masstab

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1859667A (en) * 1930-05-14 1932-05-24 J K Gruner Lumber Company Jointed lumber
JPS58219169A (ja) 1982-06-15 1983-12-20 Takeda Chem Ind Ltd オキサゾ−ル酢酸誘導体
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
US5059720A (en) * 1990-01-31 1991-10-22 E. I. Du Pont De Nemours And Company Hydroxy containing fluorovinyl compounds and polymers thereof
KR930701420A (ko) * 1990-08-23 1993-06-11 알렌 제이. 스피겔 혈당저하제로서의 하이드록시우레아 유도체
CA2075553A1 (en) * 1992-08-07 1994-02-08 George Zafir Insulated panel
AU668735B2 (en) * 1992-12-28 1996-05-16 Ig-Technical Research Inc. Refractory heat-insulating panel
JPH07188227A (ja) 1993-12-24 1995-07-25 Japan Tobacco Inc チアゾリジン誘導体及びオキサゾール誘導体
CA2157032C (en) * 1993-12-27 1999-09-28 Hisashi Shinkai Isoxazolidinedione derivative and use thereof
TW403748B (en) * 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same
IL120443A (en) * 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
US5768850A (en) * 1997-02-04 1998-06-23 Chen; Alen Method for erecting floor boards and a board assembly using the method
CN1235887C (zh) * 1998-03-30 2006-01-11 日本烟草产业株式会社 噁唑基乙醇衍生物的制备方法
DE19851200C1 (de) * 1998-11-06 2000-03-30 Kronotex Gmbh Holz Und Kunstha Fußbodenpaneele
US8234204B2 (en) * 2000-11-13 2012-07-31 Goldman, Sachs & Co. Method and system for matching short trading positions with long trading positions

Also Published As

Publication number Publication date
EP0992503A4 (de) 2001-11-07
WO1999050267A1 (fr) 1999-10-07
NO995851D0 (no) 1999-11-29
EP0992503B1 (de) 2004-02-04
ZA997705B (en) 2000-06-27
NO20024059L (no) 1999-11-29
CN1272109A (zh) 2000-11-01
EP1384722A8 (de) 2004-09-08
US6444827B2 (en) 2002-09-03
CN1235887C (zh) 2006-01-11
CZ422499A3 (cs) 2000-04-12
NO315199B1 (no) 2003-07-28
NO20024060L (no) 1999-11-29
CN1511833A (zh) 2004-07-14
CO5080736A1 (es) 2001-09-25
KR100321608B1 (ko) 2002-02-02
NO20024058L (no) 1999-11-29
CN1232511C (zh) 2005-12-21
AU2854899A (en) 1999-10-18
CN1130361C (zh) 2003-12-10
NO315197B1 (no) 2003-07-28
EP1375499A8 (de) 2004-09-08
EP0992503A1 (de) 2000-04-12
NO995851L (no) 1999-11-29
US20020188133A1 (en) 2002-12-12
ATE258931T1 (de) 2004-02-15
US6248897B1 (en) 2001-06-19
NO20024059D0 (no) 2002-08-26
EP1375499A1 (de) 2004-01-02
DE69914557T2 (de) 2005-01-05
CN1781915A (zh) 2006-06-07
IL133146A (en) 2004-02-08
SK161499A3 (en) 2000-06-12
US20010039352A1 (en) 2001-11-08
DE69914557D1 (de) 2004-03-11
US6995271B2 (en) 2006-02-07
PE20000359A1 (es) 2000-05-17
CA2291620A1 (en) 1999-10-07
NO20024060D0 (no) 2002-08-26
CA2291620C (en) 2003-10-07
IL133146A0 (en) 2001-03-19
US6699996B2 (en) 2004-03-02
CN1495174A (zh) 2004-05-12
BR9906312A (pt) 2000-07-11
HUP0003273A3 (en) 2002-02-28
NO314403B1 (no) 2003-03-17
KR20010013044A (ko) 2001-02-26
CZ296507B6 (cs) 2006-03-15
NO315198B1 (no) 2003-07-28
AR015745A1 (es) 2001-05-16
HUP0003273A2 (hu) 2002-01-28
RU2180663C2 (ru) 2002-03-20
AU738200B2 (en) 2001-09-13
US20050159466A1 (en) 2005-07-21
NO20024058D0 (no) 2002-08-26
ES2211053T3 (es) 2004-07-01
EP1384722A1 (de) 2004-01-28
JP2000143596A (ja) 2000-05-23
TWI224594B (en) 2004-12-01
NZ501896A (en) 2000-11-24

Similar Documents

Publication Publication Date Title
PL342469A1 (en) Method of obtaining stilbenic compounds
AU3091599A (en) Method of making dimethylnaphtalenes
PL337927A1 (en) Method of manufacturing compound boards
HUP0103905A3 (en) Method of producing wye-decalactone
GB9828253D0 (en) Method of well production control
SG73627A1 (en) Production method of isoxazolidnedione compound
HUP0201439A2 (en) Method of producing organic disulfides
HUP0203201A3 (en) Method for the production of adrenaline
PL341648A1 (en) Novel method of obtaining kethymin
EP0997450A4 (de) VERFAHREN ZUM REDUZIEREN VON NO x
HUP0202530A3 (en) Method for the production of phosphonomethylglycin
EG22273A (en) Production of polyamides
IL150173A0 (en) Method for production of n-phosphonomethylglycine
GB2323843B (en) Method for the production of alkoxy-and arloxy-phenols
GB9704499D0 (en) Method of manufacture
GB9802487D0 (en) Production of heptafluoropane
HUP0104214A3 (en) Improved alpha-chloronitrile production method
HUP9901699A3 (en) Process for producing of l-asparagine-acid
IL143307A0 (en) Process for the production of trifluoromethylpropane cyanohydrin
PL325802A1 (en) Method of obtaining polyestroles
PL329779A1 (en) Method of obtaining a 3-hydroxymethylcepheme compound
HU9801163D0 (en) Production method of concentrated fodder
AUPP674298A0 (en) Method of manufacture
EG24104A (en) Method of preparation of antidiphtheria
PL326399A1 (en) Method of production of carcasses of small-pelagic-fish